Latest stories on CRDF
Cardiff Oncology, Inc. (CRDF) Presents at 8th Annual RAS-Targeted Drug Development Summit - Slideshow
Seeking Alpha50 · neutralgeneral
Cardiff Oncology to Participate in September 2026 Conferences
Business Insider55 · neutralgeneral
Cardiff Oncology downgraded to Market Perform from Outperform at William Blair
The Fly42 · neutralanalyst
William Blair downgrades Cardiff Oncology stock rating on rights uncertainty
Investing.com Analyst Ratings34 · bearishanalyst
Cardiff Oncology, Inc. (CRDF) files 8-K
SEC 8-K50 · neutralgeneral
Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
Business Insider67 · bullishproduct/pr
Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
GlobeNewswire63 · neutralproduct/pr
Cardiff Oncology completes $10 million financing transaction
TipRanks24 · bearishgeneral
Cardiff Oncology, Inc. (CRDF) files 8-K
SEC 8-K50 · neutralgeneral
Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital
InvestorsHub28 · bearishgeneral
Is Cardiff Oncology, Inc. (CRDF) Stock Undervalued Amid Legal Uncertainty and Future Cancer Drug Potential?
Yahoo Top56 · neutralanalyst
Cardiff Oncology, Inc. (CRDF) files 8-K
SEC 8-K50 · neutralgeneral
Cardiff Oncology unveils promising Phase 2 onvansertib data
TipRanks67 · bullishproduct/pr
Cardiff Oncology to Participate in the Jefferies Global Healthcare Conference | CRDF Stock News
StockTitan56 · neutralgeneral
Cardiff Oncology Files Lawsuit Over Onvansertib Patent Rights
TipRanks50 · neutralgeneral